Anakinra is an IL-1 receptor antagonist.
The treatment with this drug causes slowing of process of moderate to serious rheumatoid arthritis.
The drug may be used alone or in combination with other drugs.
It is administered subcutaneously.
It may cause headache, nausea, vomiting and injection site reactions.